Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Er:YAG Laser vs Tadalafil for CP/CPPS
NCT04446598Completed
- Start
- Mar 2017
- Primary completion
- Nov 2018
- Countries
- 1
01
Overview
Open-label trial (2 arms). Primary endpoints: Maximum urethral flow value at 6 months and International Prostate Symptom Score at 12 months. Started Mar 2017; status: completed.
Beyond the preview
Go deeper on NCT04446598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04446598.